Clinical trial
Antipsychotic Medication Extended Dosing Study
NCT00431574 · Centre for Addiction and Mental Health, Other · Completed
Key facts
| NCT number | NCT00431574 |
|---|---|
| Title | Antipsychotic Medication Extended Dosing Study |
| Official title | Antipsychotic Medication Extended Dosing Study |
| Lead sponsor | Centre for Addiction and Mental Health, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Procedure |
| Interventions | dosing |
| Enrollment | 120 |
| Start date | Aug 1, 2002 |
| Primary completion | Jun 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 6, 2007 |
| Last update posted | Feb 7, 2024 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: